We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01146912
First Posted: June 22, 2010
Last Update Posted: October 7, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Melissa Stockwell, MD, MPH, Columbia University
  Purpose
The Advisory Committee on Immunization Practices (ACIP)recommends that the flu vaccine be administered annually to all children aged 6 months to 18 years as well as women who are pregnant during the influenza season. Nevertheless, targeting and mobilizing these populations has been difficult and influenza immunization rates nationwide remain low. Immunization reminder-recalls have been shown to be effective, but have had limited ability to rapidly identify and reach large target populations in a cost-effective manner. Evidence on how to optimally design these systems is not yet available and thus text message immunization alerts have not been widely implemented. The investigators propose to implement and evaluate tailored, targeted influenza text message reminders in urban pediatric and pregnant populations.

Condition Intervention
Influenza Other: Text Message Other: automated call

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Health Services Research
Official Title: TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Population

Resource links provided by NLM:


Further study details as provided by Melissa Stockwell, MD, MPH, Columbia University:

Primary Outcome Measures:
  • Influenza Immunization: Pediatric [ Time Frame: March 31, 2011 ]
    percentage of pediatric participants with influenza immunization by March 31 of 2011

  • Influenza Immunization: Pregnant Women [ Time Frame: by December 31, 2011 ]
    percentage of pregnant participants with influenza immunization by December 31, 2011

  • Influenza Immunization: Delayed Pediatric [ Time Frame: March 31, 2012 ]
    percentage of pediatric participants with influenza immunization by March 31 of 2012


Secondary Outcome Measures:
  • Pediatric: Vaccinated at Influenza Clinic [ Time Frame: March 31, 2011 ]
    percentage of pediatric participants vaccinated at an influenza immunization clinic by March 31 of 2011

  • Attendance at Appointment [ Time Frame: September-December 2011 ]
    percentage of pregnant participants who attended an appointment a reminder for from Sept-December 2011


Enrollment: 30537
Study Start Date: June 2010
Study Completion Date: April 2012
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Text message vaccine reminders
Receipt of text message vaccine reminders
Other: Text Message
Text message vaccine reminders
Other Name: Health services
Other: automated call
Automated call
Other Name: Health services
Active Comparator: automated phone call from clinic
Receipt of automated phone call from clinic
Other: automated call
Automated call
Other Name: Health services

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   6 Months to 50 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria Parents (2010-2011 and 2011-2012 influenza seasons)

  • Children aged 6 months to 18 years at the beginning of current influenza season
  • Children with one previous visit at participating pediatric community health center in last year
  • Parent with cell phone number in registry

Pregnant women Pilot (2010-2011 influenza seasons)

  • Pregnant women who will be in their 2nd or 3rd trimester during the influenza season
  • Own a cell phone with text message capability

Randomized controlled Trial (2011-2012 influenza seasons)

  • Pregnant and will be in their 2nd or 3rd trimester during the influenza season
  • Cell phone number in registry
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01146912


Locations
United States, New York
Columbia University Medical Center
New York, New York, United States, 10032
Sponsors and Collaborators
Columbia University
Investigators
Principal Investigator: Melissa S Stockwell, MD MPH Columbia University
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Melissa Stockwell, MD, MPH, Asst Prof of Pediatrics and Population and Family Health, Columbia University
ClinicalTrials.gov Identifier: NCT01146912     History of Changes
Other Study ID Numbers: AAAF0137
R40MC17169-01 ( Other Grant/Funding Number: R40MC17169-01 )
First Submitted: June 16, 2010
First Posted: June 22, 2010
Results First Submitted: August 8, 2012
Results First Posted: May 31, 2013
Last Update Posted: October 7, 2015
Last Verified: September 2015

Keywords provided by Melissa Stockwell, MD, MPH, Columbia University:
Influenza, text message, vaccination

Additional relevant MeSH terms:
Vaccines
Immunologic Factors
Physiological Effects of Drugs